Initiating antidiabetic drug therapy
Kostenbauder, H.B.
Clinical Therapeutics 30(5): 986; Author Reply 986-7
2008
ISSN/ISBN: 0149-2918 PMID: 18555946 Document Number: 619617
Document emailed within 1 workday
Related Documents
Onoya, D.; Hirasen, K.; van den Berg, L.; Miot, J.; Long, L.C.; Fox, M.P. 2018: Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa Drug Safety 41(12): 1343-1353Taylor, B.S.; Hunt, G.; Abrams, E.J.; Coovadia, A.; Meyers, T.; Sherman, G.; Strehlau, R.; Morris, L.; Kuhn, L. 2011: Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa AIDS research and human retroviruses 27(9): 945-956
Vargas, F.; Matskevitch, V.; Sarabia, Z. 1995: Photodegradation and in vitro phototoxicity of the antidiabetic drug chlorpropamide Arzneimittel-Forschung 45(10): 1079-1081
Milad, M.; Wassif, N.; Sabet, S. 1977: The pathogenesis of the teratogenic effect of the antidiabetic drug "tolbutamide": an experimental study Journal of the Egyptian Public Health Association 52(5): 356-367
Kawai, K.; Kawasaki-Tokui, Y.; Odaka, T.; Tsuruta, F.; Kazui, M.; Iwabuchi, H.; Nakamura, T.; Kinoshita, T.; Ikeda, T.; Yoshioka, T.; Komai, T.; Nakamura, K. 1997: Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs Arzneimittel-Forschung 47(4): 356-368
Haslbeck, M. 1979: New aspects of therapy with oral antidiabetic agents Wiener Medizinische Wochenschrift 199(24): 689-695
Panikar, V.; Joshi, S.R.; Deogaonkar, N.; Vadgama, J.; Nasikkar, N.; Kamat, T.; Sheikh, S.; Jain, C.C.; Wagle, T. 2018: Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic Drugs Journal of the Association of Physicians of India 66(12): 46-49
Bhatt, S.D.; Gill, T.S. 1979: Effect of a new oral antidiabetic drug HB 419 (Glibenclamide) on the plasma glucose and islet histology of two poikilotherms: Clarias batrachus and Uromastix hardwicki Indian Journal of Experimental Biology 17(10): 1122-1126
Hirsch, M.S. 2008: Initiating therapy: when to start, what to use Journal of Infectious Diseases 197(Suppl 3): S252-S260
Beringer, A. 1974: Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination Minerva Medica 65(60): 3127-3139
Smith, K.Y.; Virgil, L.A. 2004: Initiating antiretroviral therapy in asymptomatic HIV patients Journal of the National Medical Association 96(2 Suppl): 13s-16s
Graham, S.M.; Masese, L.; Gitau, R.; Jalalian-Lechak, Z.; Richardson, B.A.; Peshu, N.; Mandaliya, K.; Kiarie, J.N.; Jaoko, W.; Ndinya-Achola, J.; Overbaugh, J.; McClelland, R.S. 2010: Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment Journal of Infectious Diseases 202(10): 1538-1542
Bi, Y.; Yan, J-hua.; Liao, Z-hong.; Li, Y-bing.; Zeng, L-yi.; Tang, K-xiao.; Xue, Y-ming.; Yang, H-zhang.; Li, L.; Cai, D-hong.; Wu, G.; Zhang, F.; Lin, S-da.; Xiao, Z-hua.; Zhu, D-long.; Weng, J-ping. 2008: Inadequate glycaemic control and antidiabetic therapy among inpatients with type 2 diabetes in Guangdong Province of China Chinese Medical Journal 121(8): 677-681
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174
Sudfeld, C.R.; Wang, M.; Aboud, S.; Giovannucci, E.L.; Mugusi, F.M.; Fawzi, W.W. 2012: Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy Plos one 7(6): E40036
Mekonnen, Y.; Dukers, N.H.; Sanders, E.; Dorigo, W.; Wolday, D.; Schaap, A.; Geskus, R.B.; Coutinho, R.A.; Fontanet, A. 2003: Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians Ethiopian Medical Journal 41(Suppl 1): 61-65
Ponzo, M.G.; Hong, C.H. 2017: A Dermatologist's Guide to Infection Screening Prior to Initiating Immunosuppressive Therapy Skin Therapy Letter 22(1): 8-11
Zhurova, M.V.; Vediaeva, L.V. 1980: Determination of total and separate blood levels of nucleic acids (RNA and DNA) in states of diverse severity of diabetes mellitus and during antidiabetic therapy Terapevticheskii Arkhiv 52(8): 73-77
Ojikutu, B.O.; Zheng, H.; Walensky, R.P.; Lu, Z.; Losina, E.; Giddy, J.; Freedberg, K.A. 2008: Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa South African Medical Journal 98(3): 204-208